Robert joined CPL in 2002 to significantly strengthen the Company’s capabilities in financial and market analysis. He led CPL’s team of industry experts in a multi-million dollar distressed debt due diligence. He has worked on many ‘healthy’ ingredients, acquisition strategies and trans-Atlantic partnerships covering topics such as fine chemicals, soluble fibres, bulking agents and unusually, intra-ocular lenses.
Before that Robert spent five years in new product development and regulatory work with Inveresk (now Charles River), a contract research laboratory. Robert did his MBA at Edinburgh University, his PhD at the University of Southampton and his BSc at Imperial College, London.